Ozone therapy can help Covid-19 patients recover fast

The Ozone Forum of India, a brainchild of Bisleri Charitable Trust by Bisleri International Pvt Ltd. announced a revolutionary cure towards Covid-19 and post-Covid-19 care helping patients to recover faster.

A total of 500 patients, including across various comorbid conditions, underwent ozone therapy, out of which 77 per cent recovered within 5 days and the rest recovered by the 8 days as per clinical trials conducted in mid-2020.

The findings of the study were declared on Wednesday.

Ozone therapy has a greater impact in controlling the infection as the patient suffers from various situations such as circulatory disorders which may lead to clotting or thrombosis, headaches, lung infection, body pain and breathlessness.

Doctors recommended that ozone therapy should be taken up to 15 sessions after contracting Covid-19.

This way immunity is enhanced and patients may rebuild antioxidants in their body thus regaining their eroded strength due to the infection.

Read | How long do Covid-19 antibodies last?

Ozone Forum of India performed the trials in Lokmanya Hospital in Pune and NeuroGen Brain & Spine Institute in Mumbai.

According to Dr Mili Shah, President, Ozone Forum of India, in this crisis time of fighting the pandemic and its surge again, we need to integrate the wisdom of conventional medicine with natural healing modalities.

“We are happy to announce that ozone therapy works well on Covid-19 patients as both our trial reports showed and most importantly it is also very cost-effective. Its antimicrobial elements help patients to recover fast and also control the recurrence.”

“Both our clinical studies showed remarkable progress with ozone therapy. We used ozone therapy on healthcare workers who started developing the infection and the ones who were administered ozone therapy recovered faster. Today, when our country is seeing another spike, I would recommend using this therapy along with existing medicines in order to speed up the recovery process and curb the mutants,” added Dr. Alok Sharma, Director, NGBSI.